sulpiride has been researched along with dronabinol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Cao, XD; Mo, WY; Pan, YY; Xu, SF; Xu, ZB | 1 |
Gentleman, SM; Hedley, D; McQueen, AS; Pertwee, RG | 1 |
Carta, G; Gessa, GL; Nava, F | 1 |
Battasi, AM; Carta, G; Gessa, GL; Nava, F | 1 |
7 other study(ies) available for sulpiride and dronabinol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Effect of combination of drugs with acupuncture on analgesic efficacy.
Topics: Acupuncture Analgesia; Analgesics; Animals; Combined Modality Therapy; Diazepam; Dronabinol; Droperidol; Fenfluramine; Fentanyl; Humans; Ketamine; Pain Management; Perphenazine; Rabbits; Sulpiride | 1989 |
The hypothermic response of mice to delta-9-tetrahydrocannabinol is enhanced by chlorpromazine, thioxanthenes, alpha-adrenoceptor antagonists and pentolinium but not by SCH 23390 or sulpiride.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Benzazepines; Body Temperature; Chlorpromazine; Dronabinol; Drug Synergism; Hypothalamus, Anterior; Indoramin; Injections; Male; Mice; Pentolinium Tartrate; Phentolamine; Prazosin; Preoptic Area; Sulpiride; Thioxanthenes | 1988 |
Dopamine D(2) receptor antagonists prevent delta(9)-tetrahydrocannabinol-induced antinociception in rats.
Topics: Analgesics, Non-Narcotic; Animals; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dronabinol; Male; Nociceptors; Pain; Piperidines; Pyrazoles; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Rimonabant; Sulpiride | 1999 |
D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration.
Topics: Acetylcholine; Analgesics, Non-Narcotic; Animals; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Extracellular Space; Hippocampus; Memory; Piperidines; Pyrazoles; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Dopamine D2; Receptors, Drug; Rimonabant; Sulpiride; Time Factors | 2000 |